MECHANISMS OF MULTIDRUG RESISTANCE AND IMPLICATIONS FOR THERAPY
- 1 March 1988
- journal article
- review article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 79 (3) , 285-296
- https://doi.org/10.1111/j.1349-7006.1988.tb01588.x
Abstract
No abstract availableThis publication has 82 references indexed in Scilit:
- The mdrl gene, responsible for multidrug-resistance, codes for P-glycoproteinBiochemical and Biophysical Research Communications, 1986
- Dimethylsulfoxide, retinoic acid and 12-0-tetradecanoylphorbol-13-acetate induce a selective decrease in the phosphorylation of P150, a surface membrane phosphoprotein of HL60 cells resistant to adriamycinBiochemical and Biophysical Research Communications, 1986
- Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodiesNature, 1985
- Pleiotropic drug resistance and gene amplification in a SEWA mouse tumor cell lineExperimental Cell Research, 1985
- Gene amplification-associated cytogenetic aberrations and protein changes in vincristine-resistant Chinese hamster, mouse, and human cells.The Journal of cell biology, 1985
- Treatment of children with refractory acute lymphocytic leukemia with vincristine and diltiazemMedical and Pediatric Oncology, 1985
- Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cellsNature, 1984
- Mixed-function oxidase enzymes in adriamycin-sensitive and resistant sublines of P-388 leukemiaChemico-Biological Interactions, 1981
- Increased synthesis of a low molecular weight protein in vincristine-resistant cellsBiochemical and Biophysical Research Communications, 1981
- CHO mutants resistant to colchicine, colcemid or griseofulvin have an altered β-tubulinCell, 1980